Amended Report of Foreign Issuer (6-k/a)

FORM 6-K/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934


For the month of ….		March		……………………………………………… ,		2020



		CANON INC.
		(Translation of registrant’s name into English)

		30-2, Shimomaruko 3-Chome, Ohta-ku, Tokyo 146-8501, Japan
		(Address of principal executive offices)

[Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.


Form 20-F		X		Form 40-F

[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.


Yes				No		X

[If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82-....................

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


CANON INC.
(Registrant)


Date….	March 13, 2020	By....../s/.......... Sachiho Tanino.............
		(Signature)*




		Sachiho Tanino General Manager Consolidated Accounting Div. Canon Inc.

*Print the name and title of the signing officer under his signature.

The following materials are included.

1.	CONSOLIDATED RESULTS FOR THE FOURTH QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2019

[English summary with full translation of consolidated financial information]

Corrections to “CONSOLIDATED RESULTS FOR THE FOURTH

QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2019”

Canon announced corrections to “CONSOLIDATED RESULTS FOR THE FOURTH QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2019” disclosed on January 30, 2020, as shown in the Appendix.

Appendix

Corrections to CONSOLIDATED RESULTS FOR THE FOURTH QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2019

III . Financial Statements

7. SEGMENT INFORMATION

*Figures being corrected are underlined


(Before corrections)		Millions of yen
		Year ended December 31, 2019		Year ended December 31, 2018		Change(%)

Office
Net sales:
	External customers		1,699,653		1,804,002	-	5.8
	Intersegment		2,942		3,299	-	10.8

	Total		1,702,595		1,807,301	-	5.8

Operating cost and expenses			1,533,688		1,586,497	-	3.3

Operating profit			168,907		220,804	-	23.5

Other income (deductions)			5,390		8,383	-	35.7

Income before income taxes			174,297		229,187	-	23.9

Total assets			863,381		923,261	-	6.5
Depreciation and amortization			58,373		64,964	-	10.1
Capital expenditures			52,180		48,127	+	8.4


Imaging System
Net sales:
	External customers		806,425		969,660	-	16.8
	Intersegment		989		775	+	27.6

	Total		807,414		970,435	-	16.8

Operating cost and expenses			759,247		843,599	-	10.0

Operating profit			48,167		126,836	-	62.0

Other income (deductions)			1,499		4,179	-	64.1

Income before income taxes			49,666		131,015	-	62.1

Total assets			313,141		371,944	-	15.8
Depreciation and amortization			35,805		38,054	-	5.9
Capital expenditures			24,054		25,712	-	6.4


Medical System
Net sales:
	External customers		437,456		437,305	+	0.0
	Intersegment		1,069		273	+	291.6

	Total		438,525		437,578	+	0.2

Operating cost and expenses			411,781		408,739	+	0.7

Operating profit			26,744		28,839	-	7.3

Other income (deductions)			539		640	-	15.8

Income before income taxes			27,283		29,479	-	7.4

Total assets			273,525		247,282	+	10.6
Depreciation and amortization			11,760		9,365	+	25.6
Capital expenditures			13,158		7,454	+	76.5


Industry and Others
Net sales:
	External customers		648,165		740,970	-	12.5
	Intersegment		89,780		101,971	-	12.0

	Total		737,945		842,941	-	12.5

Operating cost and expenses			722,464		787,276	-	8.2

Operating profit			15,481		55,665	-	72.2

Other income (deductions)			82		2,181	-	96.2

Income before income taxes			15,563		57,846	-	73.1

Total assets			424,911		404,628	+	5.0
Depreciation and amortization			41,420		41,069	+	0.9
Capital expenditures			35,282		24,175	+	45.9


Corporate and Eliminations
Net sales:
	External customers		1,600		-		-
	Intersegment		(94,780)		(106,318)		-

	Total		(93,180)		(106,318)		-

Operating cost and expenses			(8,548)		(17,126)		-

Operating profit			(84,632)		(89,192)		-

Other income (deductions)			13,563		4,557		-

Income before income taxes			(71,069)		(84,635)		-

Total assets			2,893,393		2,952,350	-	2.0
Depreciation and amortization			89,969		98,102	-	8.3
Capital expenditures			86,554		95,036	-	8.9


Consolidated
Net sales:
	External customers		3,593,299		3,951,937	-	9.1
	Intersegment		-		-		-

	Total		3,593,299		3,951,937	-	9.1

Operating cost and expenses			3,418,632		3,608,985	-	5.3

Operating profit			174,667		342,952	-	49.1

Other income (deductions)			21,073		19,940	+	5.7

Income before income taxes			195,740		362,892	-	46.1

Total assets			4,768,351		4,899,465	-	2.7
Depreciation and amortization			237,327		251,554	-	5.7
Capital expenditures			211,228		200,504	+	5.3


(After corrections)		Millions of yen
		Year ended December 31, 2019		Year ended December 31, 2018		Change(%)

Office
Net sales:
	External customers		1,699,653		1,804,002	-	5.8
	Intersegment		2,942		3,299	-	10.8

	Total		1,702,595		1,807,301	-	5.8

Operating cost and expenses			1,533,688		1,586,497	-	3.3

Operating profit			168,907		220,804	-	23.5

Other income (deductions)			5,390		8,383	-	35.7

Income before income taxes			174,297		229,187	-	23.9

Total assets			863,381		923,261	-	6.5
Depreciation and amortization			58,373		64,964	-	10.1
Capital expenditures			51,623		48,127	+	7.3


Imaging System
Net sales:
	External customers		806,425		969,660	-	16.8
	Intersegment		989		775	+	27.6

	Total		807,414		970,435	-	16.8

Operating cost and expenses			759,247		843,599	-	10.0

Operating profit			48,167		126,836	-	62.0

Other income (deductions)			1,499		4,179	-	64.1

Income before income taxes			49,666		131,015	-	62.1

Total assets			313,141		371,944	-	15.8
Depreciation and amortization			35,805		38,054	-	5.9
Capital expenditures			24,016		25,712	-	6.6


Medical System
Net sales:
	External customers		437,456		437,305	+	0.0
	Intersegment		1,069		273	+	291.6

	Total		438,525		437,578	+	0.2

Operating cost and expenses			411,781		408,739	+	0.7

Operating profit			26,744		28,839	-	7.3

Other income (deductions)			539		640	-	15.8

Income before income taxes			27,283		29,479	-	7.4

Total assets			273,525		247,282	+	10.6
Depreciation and amortization			11,760		9,365	+	25.6
Capital expenditures			7,074		7,454	-	5.1


Industry and Others
Net sales:
	External customers		648,165		740,970	-	12.5
	Intersegment		89,780		101,971	-	12.0

	Total		737,945		842,941	-	12.5

Operating cost and expenses			722,464		787,276	-	8.2

Operating profit			15,481		55,665	-	72.2

Other income (deductions)			82		2,181	-	96.2

Income before income taxes			15,563		57,846	-	73.1

Total assets			424,911		404,628	+	5.0
Depreciation and amortization			41,420		41,069	+	0.9
Capital expenditures			33,515		24,175	+	38.6


Corporate and Eliminations
Net sales:
	External customers		1,600		-		-
	Intersegment		(94,780)		(106,318)		-

	Total		(93,180)		(106,318)		-

Operating cost and expenses			(8,548)		(17,126)		-

Operating profit			(84,632)		(89,192)		-

Other income (deductions)			13,563		4,557		-

Income before income taxes			(71,069)		(84,635)		-

Total assets			2,893,393		2,952,350	-	2.0
Depreciation and amortization			89,969		98,102	-	8.3
Capital expenditures			95,000		95,036	-	0.0


Consolidated
Net sales:
	External customers		3,593,299		3,951,937	-	9.1
	Intersegment		-		-		-

	Total		3,593,299		3,951,937	-	9.1

Operating cost and expenses			3,418,632		3,608,985	-	5.3

Operating profit			174,667		342,952	-	49.1

Other income (deductions)			21,073		19,940	+	5.7

Income before income taxes			195,740		362,892	-	46.1

Total assets			4,768,351		4,899,465	-	2.7
Depreciation and amortization			237,327		251,554	-	5.7
Capital expenditures			211,228		200,504	+	5.3